-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$30.00-25.72% Downside
Chinook Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover Chinook Therapeutics, Inc.?
Chinook Therapeutics, Inc. has been rated by research analysts at Wells Fargo in the past 90 days.